MGLIX | VGSCX | MGLIX / VGSCX | |
Total Expense Ratio | 0.94 | 1.99 | 47% |
Annual Report Gross Expense Ratio | 0.95 | 2.16 | 44% |
Fund Existence | 16 years | 16 years | - |
Gain YTD | -0.187 | 5.306 | -4% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.28B | 372M | 613% |
Annual Yield % from dividends | 2.60 | 1.41 | 184% |
Returns for 1 year | 0.29 | 10.70 | 3% |
Returns for 3 years | -8.44 | 4.21 | -201% |
Returns for 5 years | 20.96 | 37.35 | 56% |
Returns for 10 years | 23.99 | 40.00 | 60% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSCHX | 12.77 | N/A | N/A |
Fidelity Select Chemicals | |||
FGEAX | 25.23 | N/A | N/A |
Fidelity Advisor Glbl Capital Apprec A | |||
JACJX | 18.53 | N/A | N/A |
JHancock Mid Cap Growth A | |||
JFNNX | 63.95 | -1.31 | -2.01% |
Janus Henderson Global Life Sciences N | |||
GQSCX | 12.62 | -0.37 | -2.85% |
Glenmede Disciplined US Small Cap Eq Ptf |